Date |
Report No. |
Title |
Date Dec. 1, 2004 |
Report No. GAO-05-142R |
Title
United States Government Accountability Office Washington, DC 20548 December 1, 2004 The Honorable Joe Barton Chairman Committee on Energy and Commerce House of Representatives Subject: Medicare Chemotherapy Payments: New Drug and Administration Fees Are Closer to Providers’ Costs Dear Mr. Chairman: The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 1 (MMA) required the S... |
Date Oct. 31, 2001 |
Report No. GAO-02-53 |
Title
United States General Accounting Office GAO
October 2001 Report to Congressional Committees MEDICARE PHYSICIAN FEE SCHEDULE Practice Expense Payments to Oncologists Indicate Need For Overall Refinements
Headings for Appendix II and III corrected on 05/03/04. Printed copies of this report were correct. GAO-02-53 a Contents Letter
Results in Brief Background Oncology Fares As Well As the Average Spe... |
Date Sept. 21, 2001 |
Report No. GAO-01-1118 |
Title
United States General Accounting Office GAO
September 2001 Report to Congressional Committees MEDICARE Payments for Covered Outpatient Drugs Exceed Providers’ Cost GAO-01-1118 Contents Letter
Results in Brief Background Physicians Can Obtain Drugs Covered Under Part B for Significantly Less Than Medicare Payments Medicare Drug Payments Also Substantially Higher Than Costs for Pharmacy Supplier-B... |
Date Sept. 21, 2001 |
Report No. GAO-01-1142T |
Title
United States General Accounting Office GAO Testimony
Before the Subcommittee on Health and the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives For Release on Delivery Expected at 9:30 a.m. Friday, September 21, 2001 MEDICARE PART B DRUGS Program Payments Should Reflect Market Prices
Statement of William J. Scanlon Director, Health Care Issu... |
Date Nov. 16, 1998 |
Report No. HEHS-99-16R |
Title
GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-279966 November 16, 1998 The Honorable William M. Thomas Chairman, Subcommittee on Health Committee on Ways and Means House of Representatives The Honorable Philip M. Crane House of Representatives Subject: Medicare: Coverage of Pumas Used to Administer Intravenous Drugs Medicare’ ... |
Date April 24, 1996 |
Report No. HEHS-96-83 |
Title
United States General Accounting Office GAO
April 1996 Report to the Honorable Ron Wyden, U.S. Senate HEALTH INSURANCE Coverage of Autologous Bone Marrow Transplantation for Breast Cancer G A O years
1921 - 1996 GAO/HEHS-96-83 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-260550 April 24, 1996 The Honorable Ron Wyden United Stat... |
Date Sept. 13, 1995 |
Report No. HEHS-95-141 |
Title
United States General Accounting Office GAO
September 1995 Report to the Chairman and Ranking Minority Member, Human Resources and Intergovernmental Relations Subcommittee, House Committee on Government Reform and Oversight CANCER DRUG RESEARCH Contrary to Allegation, NIH Hydrazine Sulfate Studies Were Not Flawed GAO/HEHS-95-141 GAO United States General Accounting Office Washington, D.C. 20548 He... |
Date July 17, 1992 |
Report No. PEMD-92-28 |
Title
.‘ *“I ...J : A0
. “*-“. .-~-_I~ ...” .--. “. _.II vltdy l!l!U MEDICARE Reimbursement Policies Can Influence the Setting and Cost of Chemotherapy RESTRICTED--Not to be released outside the Y General Accounting Office unless specifically approved by the Office of Congressional Relations. United States General Accounting Of’ flce Washington, D.C. 20648 Program Evaluation and Methodolog... |
Date Sept. 27, 1991 |
Report No. PEMD-91-14 |
Title
Reimbursement Policies Constrain Physicians in Their Choice of Cancer Therapies GAO,‘ I~:MI)-9 I’ 1- I4 Program Evaluation and Methodology Division B-24286 1 September 27,lQQl The Honorable Edward M. Kennedy Chairman, Committee on Labor and Human Resources United States Senate Dear Mr. Chairman: At your request, we have studied the prevalence of off-label use of anticancer drugs; how that use ... |
Date Feb. 28, 1989 |
Report No. PEMD-89-9 |
Title
GAO
February 1989 Report to the Chairman, Subcommittee on-* Health and the Environment, Committee on Energy and Commerce, House of Representatives - BREAST C..NCER Patients’ Survival GAO/PEMD-89-9 About Our New Cover... GAO'S efforts The new color of our report covers represents the latest step in to improve the presentation of our reports. Program Evaluation and Methodology Division B-226468 Fe... |
Date Jan. 25, 1988 |
Report No. PEMD-88-12BR |
Title
e on H&&h and the’,, Environment, Committee on Energy and Commerce,House of RepresentativesI ;: _/..
January 1988 CANCER TREATMENT 197&@:- :, . *’ Program Evaluation and Methodology Division B-226468 January 25, 1988 The Bonorable Henry A. Yaxman Chairman, Subcommittee on Health and the Environment Committee on Energy and Commerce !-louse of Representatives Dear Mr. Chairman: One reason often ... |
Date March 31, 1987 |
Report No. PEMD-87-13 |
Title
*# -*-*4”mI,o-LIImI,--I* m---w- United ----- sljxtes Geueral Accounting --_--1-.-s-- O!fici GAO
0: Report xo the Chairman, Subcominkteeon I;rtte:~governmental IRelationsand Human 13esouxes, Committee on Goverrument Operations, Houseof Representatives CANCER F’ATIENT SURVIVAL What P’rogressHas &en Made?
132697 1 IIII II 1111111 IllIll B-m __- - I_ -(t-_l_---L-_(- iG/PEMD-87-13 , ,,, ,,,, ,,,,... |
Date Feb. 7, 1979 |
Report No. HRD-79-42 |
Title
REPORTB’Y’ THE- Comptroller General
OF THE UNITEDSTATES Federal Hospitals Could Improve Certain Cancer Treatment Capability By Sharing
The Chairman, House Committee on Appropriations asked GAO to review how the Department of Defense, the Veterans Administration, and the Public Health Service provide cancer care. The three agencies provide such treatment at nearly 300 Federal hospitals. About 6... |